Position in BLLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,372,037
New position
Shares Held
28,105
first reported quarter
Ownership
0.060%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#57
of 156 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 91%
Shared 0%
None 9%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Trexquant Investment LP holds $147,561,727 across 14 Diagnostics & Research names. BLLN ranks #10 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
123,380 | $64,952,167 | |
| 2 | GH |
Guardant Health, Inc.
|
159,869 | $23,985,146 | |
| 3 | A |
Agilent Technologies, Inc.
|
76,048 | $10,101,455 | |
| 4 | NTRA |
Natera, Inc.
|
35,374 | $9,602,272 | |
| 5 | ICLR |
Icon PLC
|
48,182 | $8,369,695 | |
| 6 | PSNL |
Personalis, Inc.
|
600,216 | $8,042,894 | |
| 7 | NEO |
Neogenomics Inc
|
435,783 | $6,358,073 | |
| 8 | CSTL |
Castle Biosciences Inc
|
206,111 | $4,915,747 |
All Filings in BLLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,372,037 | 28,105 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||